ARCHEMIX CORP.
Patent Owner
Stats
- 7 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Jun 26, 2012 most recent publication
Details
- 7 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 1,135 Total Citation Count
- Sep 13, 2001 Earliest Filing
- 32 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
8207298 Methods of separating biopolymer conjugated molecules from unconjugated moleculesMay 01, 09Jun 26, 12[C07H, C07K, B01D]
8105813 Materials and methods for the generation of fully 2′-modified nucleic acid transcriptsJun 30, 06Jan 31, 12[C12N]
8101385 Materials and methods for the generation of transcripts comprising modified nucleotidesDec 21, 07Jan 24, 12[C12P, C12N]
7998940 Aptamers to von Willebrand factor and their use as thrombotic disease therapeuticsJan 29, 09Aug 16, 11[C07H, A01N, C12Q, C12P]
7589073 Aptamers to von Willebrand Factor and their use as thrombotic disease therapeuticsJan 12, 06Sep 15, 09[C07H, A01N, C12Q, C12P]
7566701 Aptamers to von Willebrand Factor and their use as thrombotic disease therapeuticsSep 07, 05Jul 28, 09[C07H, A01N, C12Q, C12P]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2011/0275,701 ANTI-THROMBIN APTAMER FORMULATIONS AND METHODS FOR USEAbandonedSep 11, 09Nov 10, 11[A61K, C07H, A61P]
7767803 Stabilized aptamers to PSMA and their use as prostate cancer therapeuticsExpiredMar 07, 06Aug 03, 10[A61K]
7579450 Nucleic acid ligands specific to immunoglobulin E and their use as atopic disease therapeuticsExpiredApr 26, 05Aug 25, 09[C07H]
2009/0142,855 Polynucleotides and Polypeptides of the IL-12 Family of CytokinesAbandonedJun 30, 06Jun 04, 09[C12P, C12N, G01N, C07K]
2009/0105,172 Stabilized Aptamers to PSMA and Their Use as Prostate Cancer TherapeuticsAbandonedMar 07, 06Apr 23, 09[A61K, C07H, C12Q, A61P]
2009/0075,342 Metabolic profile directed aptamer medicinal chemistryAbandonedApr 30, 08Mar 19, 09[C07H, C12P]
2009/0053,138 Stabilized Aptamers to Platelet Derived Growth Factor and their Use as Oncology TherapeuticsAbandonedNov 02, 05Feb 26, 09[A61K, C07H, A61P]
2009/0018,093 Nucleic Acid Ligands Specific to Immunoglobuline E and Their Use as Atopic Disease TherapeuticsAbandonedDec 01, 05Jan 15, 09[A61K, C07H, C12Q, A61P, C07K]
2008/0214,489 Aptamer-mediated intracellular delivery of oligonucleotidesAbandonedMar 12, 08Sep 04, 08[A61K]
2007/0066,550 Aptamers to the human IL-12 cytokine family and their use as autoimmune disease therapeuticsAbandonedMar 07, 05Mar 22, 07[A61K, C07H]
2006/0193,821 Aptamers to the human IL-12 cytokine family and their use as autoimmune disease therapeuticsAbandonedSep 22, 05Aug 31, 06[A61K, C08G, C07K]
2006/0105,975 Aptamer-mediated intracellular delivery of therapeutic oligonucleotidesAbandonedApr 19, 05May 18, 06[A61K, C07H]
2006/0030,535 Controlled modulation of the pharmacokinetics and biodistribution of aptamer therapeuticsAbandonedMar 07, 05Feb 09, 06[A61K]
2005/0250,106 Gene knock-down by intracellular expression of aptamersAbandonedApr 23, 04Nov 10, 05[C07H, A61K, C12Q]
2005/0124,565 Stabilized aptamers to platelet derived growth factor and their use as oncology therapeuticsAbandonedJun 21, 04Jun 09, 05[A61K, C07H, C12N]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.